Last reviewed · How we verify

NCT03482297

Automated Abdominal Binder for Orthostatic Hypotension

Recruiting now Phase 1, PHASE2 Last updated 12 November 2025
What this trial tests

Phase 1, PHASE2 trial testing automated abdominal binder in Orthostatic Hypotension in 31 participants. Currently enrolling.

Timeline
1 March 2018
Primary endpoint
1 July 2026
1 December 2026

Quick facts

Lead sponsorVanderbilt University Medical Center
PhasePhase 1, PHASE2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment31
Start date1 March 2018
Primary completion1 July 2026
Estimated completion1 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 40 to 80, any sex, with Orthostatic Hypotension or Autonomic Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The automated inflatable abdominal binder is an investigational device for the treatment of orthostatic hypotension (low blood pressure on standing) in patients with autonomic failure. The purpose of this study is to determine safety and effectiveness of the automated abdominal binder in improving orthostatic tolerance in these patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Symptomatic Care in Multiple System Atrophy: State of the Art.
    Grossauer A, Sidoroff V, Heim B, Seppi K. · · 2023 · cited 11× · PMID 35581488 · DOI 10.1007/s12311-022-01411-6

Verify or expand the search:

Other recruiting trials for Orthostatic Hypotension

Currently open trials in the same condition.

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03482297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing